Related Experiment Video
Updated: Apr 18, 2026

A Method of Nodose Ganglia Injection in Sprague-Dawley Rat
Published on: November 25, 2014
Noscapine comes of age
Xue Chen1, Thu-Thuy T Dang1, Peter J Facchini1
1Department of Biological Sciences, University of Calgary, Alberta, Canada.
Noscapine, a benzylisoquinoline alkaloid from opium poppy, has a recently elucidated biosynthesis pathway. This compound shows potential as an anticancer drug, with future production possibilities via metabolic engineering.
Area of Science:
- Plant biochemistry and molecular genetics
- Natural product biosynthesis
- Pharmacology
Background:
- Noscapine is a phthalideisoquinoline alkaloid found in opium poppy (Papaver somniferum).
- It is historically used as a cough suppressant and is being investigated for anticancer properties.
- Opium poppy is the sole commercial source of noscapine.
Purpose of the Study:
- To provide a historical overview of noscapine discovery and early research.
- To detail recent breakthroughs in elucidating the noscapine biosynthetic pathway.
- To discuss pharmacological properties and potential pharmaceutical applications.
Main Methods:
- Review of historical data and scientific literature.
- Integration of findings from molecular genetics, functional genomics, and metabolic biochemistry.
- Analysis of pharmacological data for noscapine and its derivatives.
Main Results:
- The biosynthesis pathway of noscapine has been almost completely established.
- Significant progress has been made in understanding the formation of noscapine in opium poppy.
- Noscapine and its derivatives exhibit promising pharmacological activities for pharmaceutical applications.
Conclusions:
- The elucidation of noscapine biosynthesis is a major scientific achievement.
- Noscapine holds significant potential as an anticancer therapeutic.
- Future production may involve metabolic engineering and synthetic biology in plants and microbes.
More Related Videos
06:40Combined Infusion and Stimulation with Fast-Scan Cyclic Voltammetry CIS-FSCV to Assess Ventral Tegmental Area Receptor Regulation of Phasic Dopamine
Published on: April 23, 2020
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Related Concept Videos
Neurochemical Transmission: Sites of Drug Action
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Drugs Affecting Neurotransmitter Release or Uptake
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...